Downstream Processing Featured Articles

1. Stainless Steel Vial Filling System Developed For Use In Vaccine Facilities 7/17/2014

   TAP Biosystems (now part of the Sartorius Stedim Biotech Group), a leading supplier of innovative cell culture and fermentation systems for life science applications, recently announced the development of a stainless steel version of the fill-it system, designed for safely dispensing biohazardous materials such as vaccine stocks.

2. New Biofuel Process Dramatically Improves Energy Recovery 7/10/2012

   A new biofuel production process created by Michigan State University researchers produces 20 times more energy than existing methods.

3. New' Estrogen Receptor Found To Be Key Player In Tamoxifen Resistance 10/31/2008
   Researchers at Georgetown University Medical Center have discovered a novel way in which breast cancer cells become resistant to tamoxifen, the world's largest-selling breast cancer prevention and treatment drug.
4. Theraclone Sciences Secures $14M In Additional Financing 3/25/2013

   Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, recently announced a $14M financing. $8M in equity is committed from existing investors ARCH Venture Partners, Canaan Partners, MPM Capital, Healthcare Ventures, Alexandria Real Estate Equities, Amgen Ventures, Versant Ventures and Zenyaku Kogyo in a Series B Extension, bringing the total round to $50M.

5. Injection-Free Vaccination 2/5/2013

   Injection-free vaccination technique could address global vaccine challenge for diseases such as HIV and malaria

6. Scientists Help Identify A Missing Link In Taste Perception 3/6/2013

   Working with a multidisciplinary consortium of 19 researchers from nine institutions, Monell scientists have provided critical information to identify CALHM1, a channel in the walls of taste receptor cells, as a necessary component in the process of sweet, bitter, and umami (savory) taste perception.

7. Filming Bacterial Life In Multicolor As A New Diagnostic And Antibiotic Discovery Tool 10/11/2012

   An international team of scientists led by Indiana University chemist Michael S. VanNieuwenhze and biologist Yves Brun has discovered a revolutionary new method for coloring the cell wall of bacterial cells to determine how they grow, in turn providing a new, much-needed tool for the development of new antibiotics.

8. Selexys Pharmaceuticals Completes $23M Equity Financing And Signs Agreement With Global Pharmaceutical Company 9/20/2012

   Selexys Pharmaceuticals, Corp., announced today that it has successfully completed a $23 million Series A equity financing, led by MPM Capital. Additionally, Selexys entered into an agreement with Novartis Pharmaceuticals whereby Novartis has been granted an exclusive option to acquire Selexys and its lead asset, the anti-P-selectin antibody SelG1, following the successful completion of a Phase 2 clinical study in patients with sickle cell disease.

9. Pfenex Inc. Awards Althea Technologies A Contract For cGMP Manufacturing Of Circumsporozoite Protein From Plasmodium Falciparum, A Key Malaria Antigen 10/24/2012

   Pfenex Inc. recently announced that it has awarded Althea Technologies a contract for the current Good Manufacturing Practice (cGMP) manufacturing of circumsporozoite protein (CSP) from Plasmodium falciparum, an important and proven component of an effective malaria vaccine.

10. NGM Enters Agreement With Janssen To Discover And Develop Novel Therapeutics For Diabetes 1/3/2013

    NGM Biopharmaceuticals, Inc. announced recently that it has signed a worldwide agreement with Janssen Pharmaceuticals, Inc. to discover and develop novel therapeutics for the potential treatment of Type 2 diabetes and other metabolic diseases.